OT mobile menu

Search form



African American Patients Have Increased Mutation Rate in Genes Linked to Tobacco-Related Tumors

Increases in the TP53 mutation in African American men with tobacco-related cancers may be responsible for a poorer prognosis overall.

Image © Moon Light Photostudio/Shutterstock

Recent Content

Boosting NK cell infiltration into RCC tumors appears to be an attractive therapeutic option for improving the success of NK cell–based therapies and improving clinical response.

A discovery of novel biomarkers for renal cell carcinoma may lead to a diagnostic blood test that could mean earlier detection of the disease and improved patient outcomes.

Researchers have created a chimera virus that they believe may have the ability to disable certain lymphomas, paving the way for new treatment options.

A study by German investigators is elucidating the role of tyrosine kinase inhibitors in targeting FLT3 in acute myeloid leukemia.

Data presented at the ESMO 2017 Congress demonstrated that alectinib may have CNS benefit in patients with advanced ALK-positive NSCLC.

Dr. Judy Garber offers further perspective on the topic of PARP inhibitors in triple-negative breast cancer, which she presented in an education session at 2017 ESMO.

Moderate- to high-intensity exercise may lead to an acute increase in levels of epinephrine, which can reduce breast cancer cell viability and tumor growth via activation of the Hippo signaling pathway.

By clicking Accept, you agree to become a member of the UBM Medica Community.